Financials
Income statement
Fiscal date | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
---|---|---|---|---|
Total reported revenue | 32.0B | 31.1B | 30.5B | 29.4B |
Cost of revenue | 3.5B | 3.4B | 3.4B | 3.0B |
Gross profit | 28.5B | 27.7B | 27.2B | 26.4B |
Operating expense | ||||
Research & development | 5.9B | 5.6B | 5.4B | 5.6B |
Selling general and admin | 10.9B | 10.1B | 10.8B | 9.8B |
Other operating expenses | — | — | — | — |
Operating income | 11.5B | 11.8B | 10.7B | 10.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 370.2M | 337.5M | 272.2M | 277.6M |
Other income expense | 326.6M | 441.0M | -1.4B | 549.9M |
Pretax income | 11.4B | 11.9B | 10.8B | 11.1B |
Tax provision | 2.2B | 2.0B | 1.7B | 1.9B |
Net income | 9.2B | 9.9B | 9.2B | 9.2B |
Basic EPS | 0.1 | 0.1 | 0.1 | 0.1 |
Diluted EPS | 0.1 | 0.1 | 0.1 | 0.1 |
Basic average shares | 116.5B | 118.7B | 120.0B | 121.1B |
Diluted average shares | 116.8B | 119.2B | 120.6B | 121.9B |
EBITDA | 12.9B | 13.4B | 12.4B | 12.5B |
Net income from continuing op. | 9.2B | 9.9B | 9.2B | 9.2B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |